Page last updated: 2024-11-05

tolbutamide and Lymphoma, Non-Hodgkin

tolbutamide has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Howbert, JJ1
Grossman, CS1
Crowell, TA1
Rieder, BJ1
Harper, RW1
Kramer, KE1
Tao, EV1
Aikins, J1
Poore, GA1
Rinzel, SM1

Other Studies

1 other study available for tolbutamide and Lymphoma, Non-Hodgkin

ArticleYear
Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:9

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Humans; Lymphoma, Non

1990